by Danielle Medeiros | Oct 8, 2021 | Events
From October 25th to the 28th EpiVax will be represented at the Boulder Peptide Symposium in Boulder, CO by Dr. Brian Roberts, Scientific Director of Protein Therapeutics and Aimee Mattei, Immunoinformatics Program Manager, Peptide Therapeutics. Aimee and Brian will...
by Danielle Medeiros | Oct 8, 2021 | Events, Featured
EpiVax will have a large contingent at AAPS PharmSci360 in Philadelphia, October 17-20, 2021! Check out the EpiVax itinerary below! We look forward to connecting with our partners, clients, and friends in Philly. Annie De Groot, MD Speaker Spotlight: Engineering...
by Riley Nolan | Oct 6, 2021 | Events, Featured
After a postponement due to COVID travel restrictions, EpiVax is pleased to announce new dates for this year’s Amsterdam Immunogenicity & Tolerance Seminar! The seminar is now a two-day, afternoon-only format. This arrangement leaves mornings free for...
by Riley Nolan | Sep 10, 2021 | Events, Featured
EpiVax participated in the 2021 International Society for Vaccines (ISV) Annual Virtual Congress September 13-15, 2021. The 2021 Congress was a busy one, it’s been a difficult but innovative period for the vaccine development community. Multiple EpiVax...
by Riley Nolan | Jul 6, 2021 | Events, Featured
***PLEASE NOTE THIS EVENT IS CURRENTLY BEING RESCHEDULED TO A LATER DATE DUE TO COVID-19 CONSIDERATIONS**** We hope to announce a new date soon, likely Winter or Spring 2022 The Westin Tokyo 1 Chome-4-1 Mita, Meguro Tokyo, Japan 153-8580 The Westin Immunogenicity...
by Riley Nolan | May 21, 2021 | Events, Featured, Webinars
EpiVax CEO/CSO Annie De Groot and Director of Analysis Frances Terry co-presented “Engineering Better Biologics: Does Nature Know Best?” at the 2021 AAPS NBC conference May 19th 2021. Outline: Background on T cells / Immunogenicity EpiMatrix, JanusMatrix ...
